WO2001075062A3 - Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001075062A3
WO2001075062A3 PCT/CN2001/000535 CN0100535W WO0175062A3 WO 2001075062 A3 WO2001075062 A3 WO 2001075062A3 CN 0100535 W CN0100535 W CN 0100535W WO 0175062 A3 WO0175062 A3 WO 0175062A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
hydrogenase
human
polynucleotide encoding
discloses
Prior art date
Application number
PCT/CN2001/000535
Other languages
English (en)
Chinese (zh)
Other versions
WO2001075062A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Biowindow Gene Dev Inc
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biowindow Gene Dev Inc, Yumin Mao, Yi Xie filed Critical Biowindow Gene Dev Inc
Priority to AU60037/01A priority Critical patent/AU6003701A/en
Publication of WO2001075062A2 publication Critical patent/WO2001075062A2/fr
Publication of WO2001075062A3 publication Critical patent/WO2001075062A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0067—Oxidoreductases (1.) acting on hydrogen as donor (1.12)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une hydrogénase humaine 10, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, des troubles du développement, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour l'hydrogénase humaine 10.
PCT/CN2001/000535 2000-03-29 2001-03-26 Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide WO2001075062A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU60037/01A AU6003701A (en) 2000-03-29 2001-03-26 A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00115254A CN1315528A (zh) 2000-03-29 2000-03-29 一种新的多肽——人氢化酶10和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001075062A2 WO2001075062A2 (fr) 2001-10-11
WO2001075062A3 true WO2001075062A3 (fr) 2002-01-24

Family

ID=4584722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000535 WO2001075062A2 (fr) 2000-03-29 2001-03-26 Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1315528A (fr)
AU (1) AU6003701A (fr)
WO (1) WO2001075062A2 (fr)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BLATTNER F.R. ET AL.: "The complete genome sequence of escherichia coli K-12", SCIENCE, vol. 277, no. 5331, 1997, pages 1453 - 1474 *
KAWASHIMA T. ET AL.: "Determination of the complkete genomic DNA sequence of thermoplasma volvanium GSS1", PROC. JPN. ACAD., vol. 75, 1999, pages 213 - 218 *

Also Published As

Publication number Publication date
AU6003701A (en) 2001-10-15
CN1315528A (zh) 2001-10-03
WO2001075062A2 (fr) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075062A3 (fr) Nouveau polypeptide, hydrogenase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001083688A3 (fr) Nouveau polypeptide, sous-unite humaine 13 phosphatidylinositol-4-phosphate-5-kinase ii beta, et polynucleotide codant pour ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001075023A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase humaine 9, et polynucleotide codant pour ce polypeptide
WO2001088084A3 (fr) Nouveau polypeptide, superoxyde dismutase 11, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075056A3 (fr) Nouveau polypeptide, clathrine humaine a chaine legere 20, et polynucleotide codant pour ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001077287A3 (fr) Nouveau polypeptide, globine humaine de l'uterus 11, et polynucleotide codant pour ce polypeptide
WO2001075029A3 (fr) Nouveau polypeptide, facteur humain 11 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001075025A3 (fr) Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075018A3 (fr) Nouveau polypeptide, facteur humain de regulation de la transcription 31, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001081537A3 (fr) Nouveau polypeptide, sous-unite 49 humaine du facteur c(a1) 37kd de replication de l'adn, et polynucleotide codant pour ce polypeptide
WO2001083685A3 (fr) Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide
WO2001075060A3 (fr) Nouveau polypeptide, cysteine protease humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2001079427A3 (fr) Nouveau polypeptide, canal ionique humain 9 pour le chlore, et polynucleotide codant pour ce polypeptide
WO2001075014A3 (fr) Nouveau polypeptide, phosphatidylinositol-3 (ptdins 3) kinase 35 humaine, et polynucleotide codant pour ce polypeptide
WO2001094534A3 (fr) Nouveau polypeptide, facteur humain de transcription 9.57, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP